4.2 Article

Investigation of the effect of Mycobacterium bovis infection on bovine neutrophils functions

Journal

TUBERCULOSIS
Volume 93, Issue 6, Pages 675-687

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.tube.2013.07.002

Keywords

Bovine neutrophil; Mycobacterium bovis; Phagocytosis; Microbicidal mechanism; Autophagy

Funding

  1. Key Project of Ministry of Agriculture, China [30972164, 31001048, 31172293, 31272532]
  2. Special Scientific Fund for Non-profit Public Industry (Agriculture), China [200903027]
  3. Beijing Science Foundation of China [6101002]

Ask authors/readers for more resources

Bovine tuberculosis is a disease in cattle caused by infection with Mycobacterium bovis. The disease has posed significant economic losses and remains a public health hazard worldwide. Interactions between M. bovis and bovine macrophages have been extensively characterized in various studies, while similar analyses in neutrophils, which are one of the other types of white blood cells in mammals, were often overlooked. Neutrophils provide defense against all microbes and can present a diverse collection of antimicrobial molecules, which play an important role in the control of tuberculosis progression. Much of the available data about the involvement of neutrophils in the killing M. bovis is controversial. In this study, we assessed the effect of in vitro infection with M. bovis on some parameters of neutrophils functions including phenotypic changes, apoptosis rate and inflammatory cytokines production. Our results demonstrated that phagocytosis of M. bovis activated and enhanced bovine neutrophils functions as well as initialed their defense mechanism, but failed to eliminate the mycobacteria. Moreover, autophagy might get involved in the defense infection process functioning as a protective mechanism, and inducible-autophagy by lipopolysaccharides stimulation and starvation treatment could efficiently reverse the inability of neutrophils for killing M. bovis, suggesting a potential target for anti-mycobacterial drug-therapy. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available